Advertisement

Bioethics Backlash

Bioethicists debate how to remain impartial as a bioethics journal editor joins company that peddles unproven stem cell therapies.

By | February 22, 2012

Mesenchymal stem cell.WIKIMEDIA COMMONS, GHANSON

Bioethicists are debating how, or even whether, one can remain impartial when working for industry as Glenn McGee, founder and editor of the American Journal of Bioethics, joins CellTex, a company that banks patients’ cells for untested stem cell therapies, reported Nature. McGee, who joined CellTex in December of last year and will step down from AJOB on March 1, says he hopes to bring ethical standards to CellTex’s stem cell trials.

CellTex licenses therapies from RNL Bio, a South Korea-based company that converts patients’ fat cells into patient-specific mesenchymal stem cells, which the company claims can be reinjected to treat conditions like spinal cord injury. To date, no clinical trials have been completed that back these claims.

Though criticism has been leveled at McGee for joining CellTex while remaining at AJOB, observers also wonder whether bioethicists can work in industry at all. McGee has argued that bioethicists have a place in industry, thereby helping bioethics to have a practical purpose. Others, such as Insoo Hyun, a stem-cell bioethicist at Case Western Reserve University in Cleveland, Ohio, are doubtful. Hyun developed patient consent procedure for egg donation for Woo Suk Hwang, the infamous Korean stem cell researcher whose claims of human cloning later proved fraudulent.

“I know firsthand how difficult it is to separate conflict of interest—to maintain the role of bioethicist,” Hyun told Nature. “I know you need to not be too chummy with enterprises trying to speed ahead in stem cells.”

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: BobHurst

BobHurst

Posts: 31

February 22, 2012

Even bioethicists in academia have conflicts of interest that they may or may not recognize. For one, there is the "What have you done for bioethics recently?" conflict that, in my opinion, leads to invention of new rights and "protections" that may or may not be helpful to anyone. I have never seen a patient read an entire 4-page consent form. These are mandated by all the alleged protections and disclosures and weasel words inserted by the institutional lawyers. I wish someone would ask the question whether a 4 page informed consent form is really informed consent.

Avatar of:

Posts: 0

February 22, 2012

Even bioethicists in academia have conflicts of interest that they may or may not recognize. For one, there is the "What have you done for bioethics recently?" conflict that, in my opinion, leads to invention of new rights and "protections" that may or may not be helpful to anyone. I have never seen a patient read an entire 4-page consent form. These are mandated by all the alleged protections and disclosures and weasel words inserted by the institutional lawyers. I wish someone would ask the question whether a 4 page informed consent form is really informed consent.

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
BioTek
BioTek
Advertisement
NeuroScientistNews
NeuroScientistNews